Immune-mediated complications during interferon therapy in hematological patients.
about
Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunityDiscovery of new candidate genes for rheumatoid arthritis through integration of genetic association data with expression pathway analysis.Pegylated interferon de novo-induce autoimmune haemolytic anaemia in chronic hepatitis C patient.Severe autoimmune thrombocytopenic purpura during interferon-alpha therapy for chronic myelogenous leukemia.Late onset autoimmune thrombocytopenia associated with pegylated interferon-alpha-2b plus ribavirin treatment for chronic hepatitis C.Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C.Stem cell transplantation for patients with Evans syndrome.Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literatureInhibition of lupus by genetic alteration of the interferon-alpha/beta receptor.Targeting interferon-alpha: a promising approach for systemic lupus erythematosus therapy.Involvement of dendritic cells in autoimmune diseases in children.Interferon alpha sensitisation induced fatal renal insufficiency in a patient with chronic myeloid leukaemia: case report and review of literature.Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.The genetics and biology of Irf5-mediated signaling in lupus.Infiltrative lung diseases: complications of novel antineoplastic agents in patients with hematological malignancies.Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma.Delayed enhanced hepatosplenic sarcoid nodules on computed tomography in an interferon-naïve hepatitis C patient: a case report and review of the literature.Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related?Interferon-Beta-1b Induced Autoimmune Hemolytic Anemia in a Patient with MS: A Case Report.Thrombotic thrombocytopenic purpura in a patient with interferon treated hepatitis C successfully treated with rituximab.Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's DiseaseFulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient.Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy.Acquired haemophilia in a patient treated with interferon-α for hepatitis C infection.Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.Hepatitis C: the complications of immune dysfunction.Interferon-alphacon-1 treatment of three patients with severe glucocorticoid-dependent asthma. Effect on disease control and systemic glucocorticosteroid dose.Interferon-induced vitiligo in hepatitis C patients: a case series.Sarcoidosis caused by interferon therapy.
P2860
Q28246851-731D98C1-B09E-4876-B31D-A86ABFD428ABQ31158745-5022165C-9080-4C63-A9A5-DF7576E07E40Q33161405-51AD8E53-25A3-4938-B8D2-5D3C8AAEB93EQ33363838-4205EDEF-B413-48CE-A94E-3A5E115F07B8Q33370973-4331A214-91C2-4D3E-B630-4D75FA8AB16DQ33372361-62FAEAA8-F4F1-409A-83AB-94ED2C2ACCDFQ33389601-435C5EE5-9E07-42C9-86CA-6CC3ACC00066Q33424123-44B24FDB-840C-463A-8182-A9ACC13E574BQ35675526-CFE86F6A-6F03-43B3-BD83-6D1448DA1E0CQ35824498-6CF417C2-CBDB-4387-BA73-10CE764C86F7Q35946403-1A301FF7-3CB8-4013-A0C5-CBFA65788366Q36549261-D7D6442E-0F34-4C1A-8864-60500C525DA4Q36755620-4E2AFC2D-6DBC-48B7-94A2-A7AC064E2259Q36757055-08756EFC-0A06-4F6E-884F-5798BF5A10BAQ37030639-20C95117-AFB4-4B4D-B664-9B1284B89451Q37190474-902A7E61-104A-4B89-82CD-C8A12EC27370Q38262786-CCA5AD89-F270-4E35-A376-F8072583AC75Q38548408-FF087BB8-E1EA-47E7-9674-E6C935317F03Q40214998-1497A9DB-A167-4E0F-AD6E-8BBEEB4E89CBQ41978157-01C3C77B-AB8C-49EE-A745-87528DDF5C0CQ42036230-67F3819E-1663-4309-9117-8EA6BBE55AF2Q42177052-0E3A0BF7-31BB-44DE-8074-0A90F1E4E8B8Q42977642-E05BB899-9E81-4EE1-94D2-9139E5E4BB4DQ45363707-A31A6C46-EA4D-42F6-8F48-D30D37803688Q45877794-5105FD58-72C6-46E3-B67F-4880DDC1527DQ47368420-6A9CB37E-ED40-4CA6-820C-29DB9BBB03D1Q47580213-A07D2722-8781-4075-9F40-2B3E0E44CED5Q47718858-C989930B-1106-4DB1-8DC1-85254C492608Q50559290-EC5A3DDC-0AEB-47D5-903A-319842504E84Q50578170-7AA4C129-3B2C-4C1E-BF99-F04BC363A092
P2860
Immune-mediated complications during interferon therapy in hematological patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immune-mediated complications during interferon therapy in hematological patients.
@ast
Immune-mediated complications during interferon therapy in hematological patients.
@en
type
label
Immune-mediated complications during interferon therapy in hematological patients.
@ast
Immune-mediated complications during interferon therapy in hematological patients.
@en
prefLabel
Immune-mediated complications during interferon therapy in hematological patients.
@ast
Immune-mediated complications during interferon therapy in hematological patients.
@en
P356
P1433
P1476
Immune-mediated complications during interferon therapy in hematological patients.
@en
P2093
Isaac Ben-Bassat
Pia Raanani
P304
P356
10.1159/000057631
P577
2002-01-01T00:00:00Z